In a snapshot of its rare disease data, Ultragenyx boosts case for new surrogate biomarker
Ultragenyx took a step toward establishing a potential new surrogate biomarker Tuesday morning, presenting data for a rare disease with no approved treatments.
Researchers are …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.